Spravato (Esketamine Nasal Spray)

Spravato is an FDA-approved medication that offers a new approach to treating treatment-resistant depression (TRD) in adults. It contains esketamine, a form of ketamine, which works by targeting the brain’s glutamate system, a key neurotransmitter involved in mood regulation. Spravato is administered as a nasal spray and is typically used in conjunction with an oral antidepressant. This innovative treatment option provides hope to individuals who have not found relief from other depression treatments.

Clinical trials have shown that Spravato can rapidly reduce depressive symptoms, often within hours or days of the first dose. Its fast-acting nature makes it particularly beneficial for individuals experiencing severe depression or suicidal thoughts. Spravato is administered under the supervision of a healthcare professional in a certified treatment center, where patients are monitored closely for any potential side effects.

At our clinic, we offer Spravato therapy as part of our comprehensive approach to mental health treatment. Our experienced team conducts thorough evaluations to determine if Spravato is the right fit for each individual. We work closely with patients to develop personalized treatment plans and provide ongoing support throughout the therapy process. Spravato represents a significant advancement in depression care, offering new hope and a potentially life-changing solution for those living with treatment-resistant depression. If you or a loved one is struggling with depression that has not responded to other treatments, Spravato may offer a path to relief and improved quality of life.